Confirming the assay performance, higher levels of VEGF-A, IL-8 and IL-6 were observed in advanced NPDR/PDR patients compared to healthy controls (p = 3.2x10-5, p = 0.0005 and p = 0.0015, respectively). This evidence concerns the gene IL6 and non-proliferative diabetic retinopathy.